Biomedical Research Core
生物医学研究核心
基本信息
- 批准号:10707954
- 负责人:
- 金额:$ 12.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-21 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdolescentAdoptedAdultAgeAgingAtlasesAuthorization documentationBiological AssayBiologyBiomedical ResearchBiopsyCell LineCellsCessation of lifeChildChildhoodClinicalCollaborationsCommunitiesConsentDataDevelopmentDistalDrug toxicityEarly DiagnosisEnd stage renal failureEngineeringEnsureFAIR principlesGenerationsGiftsGoalsHumanHypertensionImageIncidenceInfantInfrastructureInstructionKidneyKidney DiseasesKidney FailureKnowledgeLifeLongevityMeasurementMethodsMolecularMorphologyNatureNeonatalNephrologyNephronsOrganOrgan TransplantationOrganoidsParentsPathologicPathologyPatientsPediatric ResearchPhysiologicalPoliciesPositioning AttributeProceduresProtocols documentationProviderPublishingQuality ControlReporterResearchResearch PersonnelResourcesSamplingSeveritiesSourceSpecimenTechnologyTimeTissue BanksTissue EngineeringTissue SampleTissuesTranslational ResearchTraumaUnited StatesUniversitiesWashingtonauthoritybiological researchcell typedelivery complicationsdesigndesign verificationeffective interventionepigenomefetalgene functioninduced pluripotent stem cellinnovationinterestinteroperabilitykidney cellkidney dysfunctionmolecular imagingmultimodalitymultiple omicsoperationpostnatalprematurepreservationpreventquality assurancerepositoryscreeningsingle cell technologytissue processingtranscriptomevalidation studies
项目摘要
Abstract
Pediatric Kidney BioMedical Core (pKidBIO Core)
Kidney disease is a major cause of illness and death in infants, children, and adolescents with the
incidence of end-stage kidney disease (ESKD) in these patients in the United States of about 15
per million. The rapidly increasing problems of adult hypertension and renal failure may also have
roots in pediatric kidney insults that go undetected, unprevented and untreated. The development
of effective interventions and methods of early detection and severity measurements of renal
disease in children is lagging in part due to a lack of knowledge of physiological and pathological
changes that occur as the kidney matures. Molecular blueprints would dramatically enhance our
ability to design effective approaches to intervene and prevent kidney dysfunction. This goal
cannot be met, however, without having a source of pediatric kidney tissue to begin molecular
interrogations to identify the, uniquely human and developmental, ’omic instructions required to
make and maintain healthy kidneys. The pKidBIO core, as part of the Washington University
Pediatric Center of Excellence, is in an unusually strong and unique position to provide the
required pediatric kidney tissues, originating from clinical biopsies or as “gifts of life” consented for
research, preserved with methods shown to be compatible with the most recent technologies to
enable age-specific research to dig into multi-omic single cell transcriptome and epigenome
assays, molecular imaging and tissue engineering. By its design and nature, the pKidBIO core will
promote enthusiasm and progress in pediatric kidney disease research by 1) providing human
age-specific references for fetal and childhood kidney disease tissues, 2) enabling studies aimed
to delineate cellular, morphological, physiological and molecular changes associated with postnatal
kidney maturation, 3) accelerating scientific research aimed at ex vivo human kidney organoids, 4)
establishing protocols for isolating differentiated kidney cell types at stages consistent with those
seen in kidney tissue samples, 5) advancing drug toxicity screening, and by 6) designing validation
studies of gene function and kidney engineering. The availability of the tissue and the outstanding
data generated from them will attract new expertise outside kidney research developing spatial
imaging and analytical technologies and research interested in physiological aging across the
lifespan. The pKidBIO repository will be a national resource for the research and clinical
community that is findable, accessible, interoperable, and reusable.
抽象的
小儿肾脏生物医学核心 (pKidBIO Core)
肾脏疾病是婴儿、儿童和青少年疾病和死亡的主要原因
在美国,这些患者的终末期肾病 (ESKD) 发病率约为 15
每百万人中快速增加的成人高血压和肾衰竭问题也可能有。
其根源在于儿童肾脏损伤未被发现、预防和治疗。
早期发现和严重程度测量的有效干预措施和方法
儿童疾病的滞后部分原因是缺乏生理和病理知识
随着肾脏成熟而发生的变化将极大地增强我们的能力。
设计有效方法来干预和预防肾功能障碍的能力。
然而,如果没有儿科肾组织来源来开始分子生物学研究,就无法实现这一目标。
审讯以确定独特的人类和发展的“组学指令”
pKidBIO 核心,作为华盛顿大学的一部分,制造并维持健康的肾脏。
儿科卓越中心处于异常强大和独特的地位,可以提供
所需的儿科肾组织,源自临床活检或同意作为“生命的礼物”
研究,采用与最新技术兼容的方法保存
使特定年龄的研究能够深入研究多组学单细胞转录组和表观基因组
根据其设计和性质,pKidBIO 核心将在分析、分子成像和组织工程方面发挥重要作用。
通过 1) 提供人力来促进小儿肾脏疾病研究的热情和进步
胎儿和儿童肾脏疾病组织的年龄特定参考,2) 使研究旨在
描绘与产后相关的细胞、形态、生理和分子变化
肾脏成熟,3) 加速针对离体人类肾脏类器官的科学研究,4)
建立与这些阶段一致的分离分化肾细胞类型的方案
在肾组织样本中观察到,5) 推进药物毒性筛选,以及 6) 设计验证
基因功能和肾脏工程的研究组织的可用性和突出。
从它们生成的数据将吸引肾脏研究之外的新专业知识开发空间
整个领域对生理衰老感兴趣的成像和分析技术以及研究
pKidBIO 存储库将成为研究和临床的国家资源。
可查找、可访问、可互操作和可重用的社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GLORIA S PRYHUBER其他文献
GLORIA S PRYHUBER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GLORIA S PRYHUBER', 18)}}的其他基金
Synthesis of the Multi-Modality High Resolution 3-D Atlas of Human Lung
人肺多模态高分辨率 3D 图谱的合成
- 批准号:
10689260 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
Multi-Scale Multi-Modality High Resolution Mapping of the Adult Human Lung
成人肺的多尺度多模态高分辨率测绘
- 批准号:
10689258 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
Multi-Scale Multi-Modality High Resolution Mapping of the Adult Human Lung
成人肺的多尺度多模态高分辨率测绘
- 批准号:
10530973 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung)
人肺生物分子多尺度图谱计划 (HuBMAP-Lung)
- 批准号:
10530972 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
Synthesis of the Multi-Modality High Resolution 3-D Atlas of Human Lung
人肺多模态高分辨率 3D 图谱的合成
- 批准号:
10530974 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
The Human Lung BioMolecular Multi-Scale Atlas Program (HuBMAP-Lung)
人肺生物分子多尺度图谱计划 (HuBMAP-Lung)
- 批准号:
10689257 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
Synthesis of the Multi-Modality High Resolution 3-D Atlas of Human Lung
人肺多模态高分辨率 3D 图谱的合成
- 批准号:
10928969 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
Multi-Scale Multi-Modality High Resolution Mapping of the Adult Human Lung
成人肺的多尺度多模态高分辨率测绘
- 批准号:
10928968 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
相似国自然基金
孕期母体免疫激活通过阴道菌群垂直传递并损伤子代血脑屏障促进青少年抑郁易感的作用与机制
- 批准号:82371550
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ZMYND10基因突变通过IGF信号通路调控DNAAFs功能在青少年特发性脊柱侧凸中的致病作用及机制研究
- 批准号:82360419
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
氧化应激通过m6A修饰下调凹侧肌肉干细胞ESR1表达在青少年特发性脊柱侧凸中的机制研究
- 批准号:82302657
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FUS通过调控ATP6V1C2表达参与青少年型肌萎缩侧索硬化症发生机制
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PAX3通过生肌调节因子调控椎旁肌异常发育在青少年特发性脊柱侧凸发病中的机制研究
- 批准号:82002260
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
相似海外基金
Identifying Disparities in the Cascade of Care for Medicaid-Enrolled Youth with Opioid Use Disorder
确定对参加医疗补助的患有阿片类药物使用障碍的青少年的一系列护理中的差异
- 批准号:
10701852 - 财政年份:2022
- 资助金额:
$ 12.1万 - 项目类别:
Personalized Functional Network Modeling to Characterize and Predict Psychopathology in Youth
用于表征和预测青少年精神病理学的个性化功能网络模型
- 批准号:
10630919 - 财政年份:2021
- 资助金额:
$ 12.1万 - 项目类别:
A Testing Program to Identify Novel Agents for Treatment of Pediatric and AYA High-Risk Sarcoma, Kidney and Liver Cancer
确定用于治疗儿科和 AYA 高风险肉瘤、肾癌和肝癌的新药的测试计划
- 批准号:
10652439 - 财政年份:2021
- 资助金额:
$ 12.1万 - 项目类别:
Integrative analysis of multiomic datasets for discovery of molecular underpinnings of large-scale human brain networks
多组学数据集的综合分析,以发现大规模人脑网络的分子基础
- 批准号:
10361057 - 财政年份:2021
- 资助金额:
$ 12.1万 - 项目类别:
A Randomized Controlled Trial of Sequential Bilateral Accelerated Theta Burst Stimulation in Adolescents with Suicidal Ideation Associated with Major Depressive Disorder
对患有重度抑郁症相关自杀意念的青少年进行序贯双侧加速 Theta 爆发刺激的随机对照试验
- 批准号:
10685343 - 财政年份:2020
- 资助金额:
$ 12.1万 - 项目类别: